Protocol S2210, "A Phase II Study of Neoadjuvant Carboplatin for Localized, High Risk Localized Prostate Cancer with Germline BRCA1/2 Mutations," NCT# 05806515
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Laura Graham](https://som.ucdenver.edu/FIMS/Content/faculty/35392/CU-Doctors-35392.jpg)
Laura Graham
Study ID
Protocol Number: 23-2420
More information available at ClinicalTrials.gov: NCT05806515
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers